U.S. Markets open in 1 hr 13 mins
S&P Futures
2,432.25
+0.50 (+0.02%)Dow Futures
21,314.00
-34.00 (-0.16%)
| Previous Close | 82.64 |
| Open | 82.84 |
| Bid | 83.33 x 400 |
| Ask | 85.07 x 100 |
| Day's Range | 82.84 - 84.76 |
| 52 Week Range | 64.18 - 86.72 |
| Volume | 4,891,552 |
| Avg. Volume | 3,861,946 |
| Market Cap | 88.69B |
| Beta | 0.18 |
| PE Ratio (TTM) | 40.77 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 2.08 (2.52%) |
| Ex-Dividend Date | 2017-05-11 |
| 1y Target Est | N/A |
- The Wall Street Journal•20 hours ago
Health-Care Stocks Get a Boost From Senate Bill Rollout
Health care stocks got a lift Thursday after Senate Republicans rolled out their proposed bill to repeal Obamacare.
- Market Realist•3 days ago
Analyzing Eli Lilly’s Collaboration with KeyBioscience AG
On June 8, 2017, Eli Lilly (LLY) announced a strategic collaboration with KeyBioscience AG to focus on the development of dual amylin calcitonin receptor agonists (or DACRAs).
- Market Realist•3 days ago
Key Updates on Eli Lilly’s Jardiance
Jardiance (empagliflozin) is a part of the Boehringer Ingelheim and Eli Lilly’s (LLY) diabetes alliance.